Portola Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. PTLA has around 8.3M shares in the U.S. ETF market. The largest ETF holder of PTLA is the SPDR S&P Biotech ETF (XBI), with approximately 1.91M shares. Investors may also find of interest that the ETF with the largest allocation to PTLA stock is IQ Merger Arbitrage ETF (MNA), with a portfolio weight of 2.66%. On average, U.S. ETFs allocate 0.15% of PTLA to their portfolios.
Additionally, PTLA is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PTLA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 29.93%.